NANOMEDICINE IN DRUG DELIVERY: TARGETING CANCER CELLS WITH PRECISION

Abstract

Cancer treatment continues to face significant challenges due to limitations in conventional therapies, including systemic toxicity, drug resistance, and inadequate tumor specificity. Nanomedicine has emerged as a transformative approach that leverages nanoscale materials for targeted drug delivery, offering enhanced efficacy and reduced adverse effects. This study explores the design, mechanisms, and clinical potential of various nanoparticle-based drug delivery systems (DDS), including liposomes, polymeric nanoparticles, dendrimers, and gold nanoparticles.The methodology involved a comprehensive analysis of targeting strategies—both passive and active—alongside the integration of smart nanocarriers that respond to tumor-specific stimuli such as pH, enzymes, and temperature. These systems were evaluated for their pharmacokinetics, drug release kinetics, immune response modulation, and potential for combination with gene therapy and immunotherapy.The results demonstrate that dual-targeting nanocarriers significantly improve tumor localization and intracellular drug uptake, outperforming conventional drug delivery methods. Enhanced circulation time, reduced toxicity profiles, and higher therapeutic indices were consistently observed across optimized nanoparticle platforms. Smart nanocarriers also exhibited superior specificity in delivering therapeutic agents to tumor cells, validating their role in overcoming multidrug resistance.In conclusion, nanomedicine offers a promising future for precision oncology by enabling personalized, controlled, and effective cancer treatments. While regulatory and scalability challenges remain, ongoing advances in nanoparticle engineering and clinical validation are expected to accelerate the integration of nanomedicine into mainstream oncology practice. This research underscores the need for continued interdisciplinary collaboration to realize the full therapeutic potential of nanoscale drug delivery systems in cancer care.